Shares in pharma company Affymax are down more than 80% on Monday after the company recalled its anemia drug Omontys on reports of a lethal allergic reaction that has already caused three deaths, according to the Food and Drug Administration.
This works great for finding rare side effects that would be unlikely to happen without the drug, such as liver or kidney problems or allergic reactions.